Carl Zeiss Meditec AG buy Covacoro
Summary
This prediction ended on 20.07.16 with a price of €33.52. With a performance of 45.91% the BUY prediction by Covacoro was a big success. Covacoro has 50% into this predictionCarl Zeiss Meditec AG is a German-based company that produces medical devices for ophthalmology and microsurgery. It operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment includes diagnostic and surgical equipment for the anterior and posterior segments of the eye. The Microsurgery segment offers products for neurosurgery, spinal and ENT surgeries, and dental applications. The company has a global reach and serves customers in more than 115 countries through its subsidiaries and distribution network. Carl Zeiss Meditec has been listed on the Frankfurt and TecDAX stock exchanges since 2007.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Carl Zeiss Meditec AG | -6.734% | -6.734% | -22.006% | -68.529% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by Covacoro for this prediction
In the thread Carl Zeiss Meditec AG diskutieren
Medtech mit Durchblick
Carl Zeiss Meditec ist ein weltweit im Bereich Medizintechnik agierendes Unternehmen, das auf Instrumente für Augenuntersuchungen, Operationsmikroskope, medizinische Laser und Intraokularlinsen spezialisiert ist.
Umsatz und Gewinn haben kontinuierlich zugelegt, siehe z.B. Ariva:
http://www.ariva.de/fundamentaldaten/kompakt.m?secu=22
In 2015 erwarte ich einen Umsatz > 1 Mrd und Gewinn > 1,10 Euro je Aktie, je nach USD/EUR Wechselkurs kann es auch deutlich mehr werden, daher Kaufempfehlung.